8-K filed April 17, 2026, 7:59 PM ET ticker EBS CIK 0001367644

debt confidence high sentiment positive materiality 0.60

Emergent BioSolutions closes $150M Term Loan with OrbiMed, extends maturities, cuts interest expense 200 bps

Emergent BioSolutions Inc.

New $150M Term Loan with OrbiMed matures April 2031, replaces prior $150M OHA facility; ABL reduced to $50M.
Interest expense on Term Loan reduced by 200 basis points annually (Term SOFR + 6.25%, floor 3%).
Delayed draw term loan of $75M available for 24 months for acquisitions/growth capex.
Maturities extended to April 2031 from August 2029 (Term Loan) and Sept 2029 (ABL).
Company expects lower interest expense and enhanced flexibility to support transformation plan.

item 1.01 item 1.02 item 3.02 item 2.03 item 7.01 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001367644-26-000038
form_type: 8-K
ticker: EBS
cik: 0001367644
company_name: Emergent BioSolutions Inc.
filed_at: 2026-04-17T23:59:59+00:00
discovered_at: 2026-05-14T18:02:32.195858+00:00
generated_at: 2026-05-15T05:28:55.883496+00:00
sec_items: ["1.01", "1.02", "3.02", "2.03", "7.01", "9.01"]
event_type: debt
sentiment: positive
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001367644-26-000038
json_url: https://secwatch.observer/filing/0001367644-26-000038.json
markdown_url: https://secwatch.observer/filing/0001367644-26-000038.md
text_url: https://secwatch.observer/filing/0001367644-26-000038.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1367644/000136764426000038/0001367644-26-000038-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1367644/000136764426000038/ebs-20260416.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Source-grounded claims

fe09344dad4ce3cd5c0d64f15a1c6e6495d2794b

Emergent BioSolutions Inc. incurred term loan of $150 million with OrbiMed Royalty & Credit Opportunities V, LP at Term SOFR (subject to a floor of 3.00%) plus 6.25% per annum maturing April 16, 2031.

The Term Loan Agreement provides for (i) a term loan (the “Initial Term Loan”) in an aggregate principal amount equal to $150 million, which was drawn in full on the date of entry into the Term Loan Agreement (the “Closing Date”)

SEC 8-K Item 2.03/2.04 confidence 0.9 SEC evidence

8154ff82b7561e31920c4bfe671756d9531835b6

Emergent BioSolutions Inc. entered into Term Loan Agreement with OrbiMed Royalty & Credit Opportunities V, LP valued at $150 million (effective 2026-04-16).

On April 16, 2026, Emergent BioSolutions Inc. (the “Company”) entered into a Credit Agreement (the “Term Loan Agreement”) by and among the Company, the lenders from time to time party thereto, and OrbiMed Royalty & Credit Opportunities V, LP, as administrative agent

SEC 8-K Item 1.01/1.02 confidence 0.99 SEC evidence

a96585b7909aed6902767fe8e3ae1006c64a9f8c

Emergent BioSolutions Inc. terminated Prior Credit Agreement with OHA Agency LLC.

repay all amounts outstanding and terminate commitments under the Credit Agreement dated as of August 30, 2024, by and among the Company, the lenders from time to time party thereto and OHA Agency LLC as administrative agent (as amended, the "Prior Credit Agreement")

SEC 8-K Item 1.01/1.02 confidence 0.95 SEC evidence

Comparable filings

EMAT

EMAT secures $100M convertible debenture facility from Yorkville; first $20M tranche issued

Evolution Metals & Technologies Corp. May 11, 2026, 7:59 PM ET debt Items 1.01, 2.03, 3.02, 7.01, 9.01

same fact type: debt_financing, material_agreement same SEC item: 1.01, 2.03, 3.02, 7.01, 9.01 same event type: debt similar materiality

This filing

The Term Loan Agreement provides for (i) a term loan (the “Initial Term Loan”) in an aggregate principal amount equal to $150 million, which was drawn in full on the date of entry into the Term Loan Agreement (the “Closing Date”)

Comparable filing

The first Convertible Debenture (the “First Debenture”) in the principal amount of $20,000,000 was issued on May 7, 2026.

Filing page SEC filing

TCPC

BlackRock TCP Capital closes $535.8M CLO securitization, repays existing debt facilities

BlackRock TCP Capital Corp. June 1, 2026, 4:50 PM ET debt Items 1.01, 1.02, 2.03, 9.01

same fact type: debt_financing, material_agreement same SEC item: 1.01, 1.02, 2.03, 9.01 same event type: debt similar materiality

This filing

The Term Loan Agreement provides for (i) a term loan (the “Initial Term Loan”) in an aggregate principal amount equal to $150 million, which was drawn in full on the date of entry into the Term Loan Agreement (the “Closing Date”)

Comparable filing

Item 1.01. Entry into a Material Definitive Agreement. On May 27, 2026 (the " Closing Date "), BlackRock TCP Capital Corp. (the " Company "), through its subsidiary, completed a $535,780,000 securitization of certain loans held by a subsidiary of the Company (the " CLO Transaction "). On the Closing Date and in connection with the CLO Transaction, BlackRock DLF 2026-C

Filing page SEC filing

ILPT

ILPT Mountain JV closes $1.62B loan at 5.71% fixed, repays $1.6B existing debt

Industrial Logistics Properties Trust May 8, 2026, 7:59 PM ET debt Items 1.01, 1.02, 2.03, 9.01

same fact type: debt_financing, material_agreement same SEC item: 1.01, 1.02, 2.03, 9.01 same event type: debt similar materiality

This filing

The Term Loan Agreement provides for (i) a term loan (the “Initial Term Loan”) in an aggregate principal amount equal to $150 million, which was drawn in full on the date of entry into the Term Loan Agreement (the “Closing Date”)

Comparable filing

Stanley Bank, N.A., Bank of America, N.A., Bank of Montreal and UBS AG New York Branch, or collectively, the lenders, pursuant to which Mountain JV obtained, in aggregate, a $1.62 billion loan secured by 90 of its properties, or the Loan . Also on May 8, 2026, we entered into a guaranty in favor of the lenders, pursuant to which we guaranteed certain limited

Filing page SEC filing

VIASP

Via Renewables enters $300M senior secured revolving credit facility, replaces prior agreement

Via Renewables, Inc. May 8, 2026, 7:59 PM ET debt Items 1.01, 1.02, 2.03, 3.03, 9.01

same fact type: debt_financing, material_agreement same SEC item: 1.01, 1.02, 2.03, 9.01 same event type: debt similar materiality

This filing

The Term Loan Agreement provides for (i) a term loan (the “Initial Term Loan”) in an aggregate principal amount equal to $150 million, which was drawn in full on the date of entry into the Term Loan Agreement (the “Closing Date”)

Comparable filing

In connection with entering into the Credit Agreement, the Company entered into an amended and restated subordinated promissory note (Note No. 9) (the “Subordinated Debt Facility”) with Spark HoldCo and Retailco, LLC (“Retailco”). The Subordinated Debt Facility allows the Company to draw advances in increments of no less than $1.0 million per advance up to $25.0 million through November 6, 2029.

Filing page SEC filing

RNST

Renasant prices $300M 6.25% sub notes due 2036, net $295.7M, may redeem $40M 5.50% notes

RENASANT CORP May 7, 2026, 7:59 PM ET debt Items 1.01, 2.03, 7.01, 9.01

same fact type: debt_financing, material_agreement same SEC item: 1.01, 2.03, 7.01, 9.01 same event type: debt similar materiality

This filing

The Term Loan Agreement provides for (i) a term loan (the “Initial Term Loan”) in an aggregate principal amount equal to $150 million, which was drawn in full on the date of entry into the Term Loan Agreement (the “Closing Date”)

Comparable filing

for the issuance and sale of $300 million aggregate principal amount of its 6.25% Fixed-to-Floating Rate Subordinated Notes due 2036

Filing page SEC filing

HR subsidiary issues $700M 3.00% exchangeable senior notes due 2032

Healthcare Realty Trust Inc May 7, 2026, 7:59 PM ET debt Items 1.01, 2.03, 3.02, 9.01

same fact type: debt_financing, material_agreement same SEC item: 1.01, 2.03, 3.02, 9.01 same event type: debt similar materiality

This filing

The Term Loan Agreement provides for (i) a term loan (the “Initial Term Loan”) in an aggregate principal amount equal to $150 million, which was drawn in full on the date of entry into the Term Loan Agreement (the “Closing Date”)

Comparable filing

issued $700,000,000 aggregate principal amount of its 3.00% Exchangeable Senior Notes due 2032

Filing page SEC filing

EHC

Encompass Health issues $500M 5.875% notes due 2034; to redeem $400M of 4.500% notes due 2028

Encompass Health Corp June 1, 2026, 4:26 PM ET debt Items 1.01, 2.03, 9.01

same fact type: debt_financing, material_agreement same SEC item: 1.01, 2.03, 9.01 same event type: debt similar materiality

This filing

The Term Loan Agreement provides for (i) a term loan (the “Initial Term Loan”) in an aggregate principal amount equal to $150 million, which was drawn in full on the date of entry into the Term Loan Agreement (the “Closing Date”)

Comparable filing

On May 29, 2026, Encompass Health Corporation (the “Company”) completed the issuance and sale of $500 million in aggregate principal amount of its 5.875% Senior Notes due 2034 (the “Notes”), along with the related guarantees of the Notes by certain of the Company’s subsidiaries (the “Guarantees”), in a private offering.

Filing page SEC filing

VVX

V2X refinances $868.5M term loans with new tranche maturing 2030; SOFR+2% margin

V2X, Inc. June 1, 2026, 4:10 PM ET debt Items 1.01, 2.03, 9.01

same fact type: debt_financing, material_agreement same SEC item: 1.01, 2.03, 9.01 same event type: debt similar materiality

This filing

The Term Loan Agreement provides for (i) a term loan (the “Initial Term Loan”) in an aggregate principal amount equal to $150 million, which was drawn in full on the date of entry into the Term Loan Agreement (the “Closing Date”)

Comparable filing

The Amendment provides for, among other things, a new tranche of term loans under the Credit Agreement in an aggregate original principal amount of $868,522,978.38 (the “New Term Loans”), which New Term Loans replace or refinance in full all of the existing term loans outstanding under the Credit Agreement (as in effect immediately prior to the Amendment), as further set forth in the Amendment. The New Term Loans mature on December 6, 2030.

Filing page SEC filing

Source: SEC EDGAR

accession 0001367644-26-000038

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.